UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 22, 2024

Talkspace, Inc.
 (Exact name of registrant as specified in its charter)


Delaware
001-39314
84-4636604
(State or other jurisdiction of incorporation)
(Commission  File Number)
(I.R.S. Employer  Identification No.)

622 Third Avenue, New York, New York 10017
(Address of principal executive offices)
(Zip Code)
 
(212) 284-7206
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a‑12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class

Trading
Symbol(s)

Name of each exchange
on which registered
Common stock, $0.0001 par value per share

TALK

Nasdaq Global Select Market
Warrants to purchase common stock

TALKW

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐



Item 7.01.
Regulation FD Disclosure.
 
On February 22, 2024, Talkspace, Inc. (the “Company”) issued a press release announcing the events discussed in Item 8.01 below, the text of which is furnished as Exhibit 99.1 hereto and incorporated herein by reference. The information contained in this Item 7.01 and Exhibit 99.1 is being furnished, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under Section 18. Furthermore, the information contained in this Item 7.01 and Exhibit 99.1 shall not be deemed to be incorporated by reference into the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act.
 
Item 8.01.
Other Events.
 
On February 22, 2024, the Company announced that its Board of Directors (“Board”) has approved a share repurchase program which authorizes the repurchase of up to $15 million of the currently outstanding shares of the Company’s common stock over a period of twenty-four months beginning on March 1, 2024 (the “Repurchase Program”).  Under the Repurchase Program, the Company may repurchase shares through various methods, including open market purchases and privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 of the Securities Exchange Act of 1934 (the “Exchange Act”). Such purchases will be at times and in amounts as the Company deems appropriate, based on factors such as price, market conditions, corporate and regulatory requirements, constraints specified in any Rule 10b5-1 trading plans, alternative investment opportunities and other business considerations.

 The Repurchase Program does not obligate the Company to repurchase any dollar amount or number of shares, and may be suspended or terminated at any time.

Information regarding share repurchases will be available in the Company’s periodic reports on Form 10-Q and 10-K filed with the Securities and Exchange Commission as required by the applicable rules of the Exchange Act.
 
Item 9.01.
Financial Statements and Exhibits.

(d)
Exhibits

Exhibit
Number
Description
Press Release issued by Talkspace, Inc., dated February 22, 2024.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 



Talkspace, Inc.



Date:     February 22, 2024
By:
/s/ Jennifer Fulk



Jennifer Fulk


Chief Financial Officer




Exhibit 99.1


Talkspace Announces Fourth Quarter and Full Year 2023 Results
 
4Q 2023 Payor revenue grew 138% year-over-year
 
4Q 2023 Operating expenses of $23.6 million, down 37% year-over-year
 
4Q 2023 Net loss of $1.3 million; Adjusted EBITDA1 loss of $0.3 million, an improvement of 97% year-over-year
 
Provides 2024 guidance with revenue $185-$195 million and adjusted EBITDA1 $4-$8 million
 
Announces Initial Share Repurchase Program of $15M

NEW YORK, New York - February 22, 2024Talkspace, Inc. (NASDAQ: TALK), today reported fourth quarter and full year 2023 financial results.


 
Three Months
   
Full Year
 
Unaudited
     
Year Ended December 31, 2023
 
Results
   
Variance from
Prior Year %
   
Results
   
Variance from
Prior Year %
 
(In thousands unless otherwise noted)
                       
Number of eligible lives at year end (in millions)
   
131
     
42
%
   
131
     
42
%
Number of completed Payor sessions
   
249.8
     
95
%
   
850.6
     
99
%
Number of Consumer active members at year end
   
11.7
     
(24
)%
   
11.7
     
(24
)%
                                 
Total revenue
 
$
42,418
     
40
%
 
$
150,045
     
25
%
Gross profit
 
$
20,971
     
30
%
 
$
74,380
     
23
%
Gross margin %
   
49.4
%
           
49.6
%
       
Operating expenses
 
$
23,554
     
(37
)%
 
$
97,589
     
(32
)%
Net loss
 
$
(1,306
)
   
93
%
 
$
(19,182
)
   
76
%
Adjusted EBITDA1
 
$
(306
)
   
97
%
 
$
(13,529
)
   
77
%
Cash and cash equivalents at year end
 
$
123,908
     
   
$
123,908
     
 
 
(1) Adjusted EBITDA is a non-GAAP financial measure. For a definition of the measure and a reconciliation to the most directly comparable GAAP measure, see “Reconciliation of Non-GAAP Results to GAAP Results.”

Dr. Jon Cohen, CEO of Talkspace, said, “2023 was a pivotal year for Talkspace, demonstrating our commitment to strategic execution. Our achievements and streamlined strategy have significantly fortified our foundation for 2024. We're poised for substantial growth in Payor revenue and continue to lead in covered mental healthcare. The opportunities in Direct to Enterprise (“DTE”) are vast, and with our scalable infrastructure, we are set for profitable expansion.”

Jennifer Fulk, CFO of Talkspace, said, “The strategic measures we've implemented throughout the past year have significantly strengthened our financial foundation and operational efficiency. Our disciplined approach to cost management and investment in scalable capabilities have not only enhanced our operating leverage but also positioned us well for sustained profitable growth.”

1

Fourth Quarter 2023 Key Performance Metrics

 
Revenue increased 40% over the prior-year period to $42.4 million, driven by a 138% year-over-year increase in Payor revenue and a 3% year-over-year increase in DTE revenue; partially offset by a 26% year-over-year consumer revenue decline.
 

Gross profit increased 30% over the prior-year period to $21.0 million, and gross margin declined to 49.4% from 53.5% year-over-year, driven by a shift in revenue mix towards Payor consistent with our strategic objectives.
 

Operating expenses were $23.6 million, down 37% year-over-year, driven by a reduction across all of our operating cost categories.
 

Net loss was $(1.3) million, an improvement from $(18.3) million net loss in the fourth quarter of 2022, primarily driven by lower operating expenses, and an increase in revenue.
 
Full Year 2023 Key Performance Metrics


Revenue increased 25% over the prior year to $150.0 million, driven by a 123% year-over-year increase in Payor revenue and a 19% year-over-year increase in DTE revenue; partially offset by a 35% year-over-year consumer revenue decline.
 

Gross profit increased 23% over the prior year to $74.4 million, and gross margin declined to 49.6% from 50.5% year-over-year, driven by a shift in revenue mix towards Payor.
 

Operating expenses were $97.6 million, down 32% year-over-year, driven by a reduction across all of our operating cost categories.
 

Net loss was $(19.2) million, an improvement from $(79.7) million net loss in 2022, primarily driven by lower operating expenses, and an increase in revenue.
 
Financial Guidance

The following guidance is based on current market conditions and expectations and the information available to the Company today:


For 2024 Talkspace expects revenue to be in the range of $185 million to $195 million, and adjusted EBITDA to be in the range of $4 million to $8 million.
 
Share Repurchase Program

The Company’s Board of Directors has approved an initial share repurchase program authorizing the Company to repurchase up to fifteen million dollars ($15,000,000) of its outstanding shares of common stock over the next twenty-four months. The Company may repurchase the shares periodically through various methods in compliance with applicable state and federal securities laws. The timing of purchases, the target number of shares and the pricing per purchase will be determined by Management at its discretion. Such repurchases will be funded from cash on hand. The repurchase program may be modified, suspended, or discontinued at any time at the Company’s discretion without prior notice.

2

Conference Call, Presentation Slides, and Webcast Details
 
The conference call will be available via audio webcast at investors.talkspace.com and can also be accessed by dialing (888) 330-2391 for U.S. participants, or +1 (240) 789-2702 for international participants, and referencing participant code 2348878. A replay will be available shortly after the call’s completion and remain available for approximately 90 days.
 
About Talkspace
 
Talkspace (NASDAQ: TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall health and should be available to everyone.
 
Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+). With Talkspace’s core therapy offerings, members are matched with one of thousands of licensed therapists within days and can engage in live video, audio, or chat sessions, and/or unlimited asynchronous text messaging sessions.
 
All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. More than 130 million Americans have access to Talkspace through their health insurance plans, employee assistance programs, our partnerships with leading healthcare companies, or as a free benefit through their employer, school, or government agency.
 
For more information, visit www.talkspace.com.

For Investors:
 
Neal Nagarajan
Sloane & Company
(301) 273-5662
nnagarajan@sloanepr.com

For Media:
 
John Kim
SKDK
(310) 997-5963
jkim@skdknick.com

3

Forward Looking Statements
 
This press release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, anticipated financial performance, achieving profitability, business strategy and plans, market opportunity and expansion and objectives of our management for future operations. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast”, “future”, “intend,” “may,” “might”, “opportunity”, “plan,” “possible”, “potential,” “predict,” “project,” “should,” “strategy”, “strive”, “target,” “will,” or “would”, the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many important factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to factors and the other risks and uncertainties described under the caption “Risk Factors” in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 10, 2023, and our other documents filed from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and we assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise unless required to do so under applicable law. We do not give any assurance that we will achieve our expectations.

4

Talkspace, Inc.
Consolidated Statements of Operations

   
Three Months Ended
December 31,
         
Year Ended
December 31,
       
   
2023
   
2022
   
% Change
   
2023
   
2022
   
% Change
 
(in thousands, except percentages, share and  per share data)
 
Unaudited
         
Unaudited
             
Revenue:
                                   
Payor revenue
 
$
25,362
   
$
10,665
     
137.8
   
$
80,823
   
$
36,168
     
123.5
 
DTE revenue
   
8,897
     
8,615
     
3.3
     
33,614
     
28,241
     
19.0
 
Consumer revenue
   
8,159
     
10,961
     
(25.6
)
   
35,608
     
55,158
     
(35.4
)
Total revenue
   
42,418
     
30,241
     
40.3
     
150,045
     
119,567
     
25.5
 
Cost of revenues
   
21,447
     
14,066
     
52.5
     
75,665
     
59,229
     
27.7
 
Gross profit
   
20,971
     
16,175
     
29.7
     
74,380
     
60,338
     
23.3
 
Operating expenses:
                                               
Research and development, net
   
3,867
     
4,866
     
(20.5
)
   
17,571
     
21,659
     
(18.9
)
Clinical operations, net
   
1,478
     
277
     
433.6
     
6,159
     
6,591
     
(6.6
)
Sales and marketing
   
12,846
     
14,128
     
(9.1
)
   
52,544
     
72,842
     
(27.9
)
General and administrative
   
5,363
     
11,801
     
(54.6
)
   
21,315
     
36,270
     
(41.2
)
Impairment of goodwill
   
     
6,134
     
(100.0
)
   
     
6,134
     
(100.0
)
Total operating expenses
   
23,554
     
37,206
     
(36.7
)
   
97,589
     
143,496
     
(32.0
)
Operating loss
   
(2,583
)
   
(21,031
)
   
87.7
     
(23,209
)
   
(83,158
)
   
72.1
 
Financial (income), net
   
(1,330
)
   
(2,851
)
   
(53.3
)
   
(4,245
)
   
(3,740
)
   
13.5
 
Loss before taxes on income
   
(1,253
)
   
(18,180
)
   
93.1
     
(18,964
)
   
(79,418
)
   
76.1
 
Taxes on income
   
53
     
127
     
(58.3
)
   
218
     
254
     
(14.2
)
Net loss
 
$
(1,306
)
 
$
(18,307
)
   
92.9
   
$
(19,182
)
 
$
(79,672
)
   
75.9
 
Net loss per share:
                                               
Basic and Diluted
 
$
(0.01
)
 
$
(0.11
)
   
90.9
   
$
(0.12
)
 
$
(0.51
)
   
76.5
 
Weighted average number of common shares:
                                               
Basic and Diluted
   
167,485,398
     
159,343,311
             
165,039,920
     
156,885,256
         

5

Talkspace, Inc.
Consolidated Balance Sheets
 
   
December 31, 2023
   
December 31, 2022
 
(in thousands)
 
Unaudited
       
ASSETS
           
CURRENT ASSETS:
           
Cash and cash equivalents
 
$
123,908
   
$
138,545
 
Accounts receivable
   
10,174
     
9,640
 
Other current assets
   
5,718
     
4,372
 
Total current assets
   
139,800
     
152,557
 
Property and equipment, net
   
314
     
677
 
Intangible assets, net
   
1,786
     
2,529
 
Other assets
   
321
     
491
 
Total assets
 
$
142,221
   
$
156,254
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
CURRENT LIABILITIES:
               
Accounts payable
 
$
6,111
   
$
6,461
 
Deferred revenues
   
3,069
     
4,355
 
Accrued expenses and other current liabilities
   
12,468
     
16,502
 
Total current liabilities
   
21,648
     
27,318
 
Warrant liabilities
   
1,842
     
939
 
Other liabilities
   
85
     
461
 
Total liabilities
   
23,575
     
28,718
 
STOCKHOLDERS’ EQUITY:
               
Common stock
   
16
     
16
 
Additional paid-in capital
   
389,014
     
378,722
 
Accumulated deficit
   
(270,384
)
   
(251,202
)
Total stockholders’ equity
   
118,646
     
127,536
 
Total liabilities and stockholders’ equity
 
$
142,221
   
$
156,254
 

6

Talkspace, Inc.
Consolidated Statements of Cash Flows

   
Year Ended
December 31,
 
   
2023
   
2022
 
(in thousands)
 
Unaudited
       
Cash flows from operating activities:
           
Net loss
 
$
(19,182
)
 
$
(79,672
)
Adjustments to reconcile net loss to net cash used in operating activities:
               
Depreciation and amortization
   
1,196
     
1,357
 
Stock-based compensation
   
8,395
     
12,116
 
Remeasurement of warrant liabilities
   
903
     
(3,131
)
Impairment of goodwill
   
     
6,134
 
Increase in accounts receivable
   
(534
)
   
(4,126
)
(Increase) decrease in other current assets
   
(1,346
)
   
5,080
 
Decrease in accounts payable
   
(350
)
   
(968
)
Decrease in deferred revenues
   
(1,286
)
   
(2,831
)
(Decrease) increase in accrued expenses and other current liabilities
   
(4,034
)
   
4,862
 
Other
   
(155
)
   
102
 
Net cash used in operating activities
   
(16,393
)
   
(61,077
)
Cash flows from investing activities:
               
Purchase of property and equipment
   
(151
)
   
(350
)
Proceeds from sale of property and equipment
   
10
     
33
 
Net cash used in investing activities
   
(141
)
   
(317
)
Cash flows from financing activities:
               
Proceeds from exercise of stock options
   
2,707
     
3,181
 
Payments for employee taxes withheld related to vested stock-based awards
   
(810
)
   
(853
)
Payments for reverse capitalization, net of transaction costs
   
     
(645
)
Net cash provided by financing activities
   
1,897
     
1,683
 
Net decrease in cash and cash equivalents
   
(14,637
)
   
(59,711
)
Cash and cash equivalents at the beginning of the year
   
138,545
     
198,256
 
Cash and cash equivalents at the end of the year
 
$
123,908
   
$
138,545
 

7

Non-GAAP Financial Measures
 
In addition to our financial results determined in accordance with GAAP, we believe adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance, and our management uses it as a key performance measure to assess our operating performance. Because adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes and in evaluating acquisition opportunities. We also use adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. We believe that the use of adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.
 
Some of the limitations of adjusted EBITDA include (i) adjusted EBITDA does not necessarily reflect capital commitments to be paid in the future and (ii) although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and adjusted EBITDA does not reflect these requirements. In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments described herein. Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. Our adjusted EBITDA may not be comparable to similarly titled measures of other companies because they may not calculate adjusted EBITDA in the same manner as we calculate the measure, limiting its usefulness as a comparative measure. Adjusted EBITDA should not be considered as an alternative to loss before income taxes, net loss, loss per share, or any other performance measures derived in accordance with U.S. GAAP. When evaluating our performance, you should consider adjusted EBITDA alongside other financial performance measures, including our net loss and other GAAP results.
 
A reconciliation is provided below for adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review our financial statements prepared in accordance with GAAP and the reconciliation of our non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. We do not provide a forward-looking reconciliation Adjusted EBITDA guidance as the amount and significance of the reconciling items required to develop meaningful comparable GAAP financial measures cannot be estimated at this time without unreasonable efforts. These reconciling items could be meaningful.

8

Adjusted EBITDA
 
We calculate adjusted EBITDA as net loss adjusted to exclude (i) depreciation and amortization, (ii) interest and other expenses (income), net, (iii) tax benefit and expense, (iv) stock-based compensation expense, (v) impairment of goodwill, and (vi) certain non-recurring expenses, where applicable.

Talkspace, Inc.
Reconciliation of Non-GAAP Results to GAAP Results

   
Three Months Ended
December 31,
   
Year Ended
December 31,
 
   
2023
   
2022
   
2023
   
2022
 
(in thousands)
 
Unaudited
   
Unaudited
 
Net loss
 
$
(1,306
)
 
$
(18,307
)
 
$
(19,182
)
 
$
(79,672
)
Add:
                               
Depreciation and amortization
   
283
     
351
     
1,285
     
1,357
 
Financial (income), net (1)
   
(1,330
)
   
(2,851
)
   
(4,245
)
   
(3,740
)
Taxes on income
   
53
     
127
     
218
     
254
 
Stock-based compensation
   
1,994
     
2,730
     
8,395
     
12,116
 
Impairment of goodwill
   
     
6,134
     
     
6,134
 
Non-recurring expenses (2)
   
     
2,947
     
     
4,880
 
Adjusted EBITDA
 
$
(306
)
 
$
(8,869
)
 
$
(13,529
)
 
$
(58,671
)

(1)  For the three months ended December 31, 2023, financial (income), net, primarily consisted of $1.6 million of interest income from our money market accounts partially offset by $0.3 million in losses resulting from the remeasurement of warrant liabilities. For the year ended December 31, 2023, financial (income), net, primarily consisted of $5.3 million of interest income from our money market accounts partially offset by $0.9 million in losses resulting from the remeasurement of warrant liabilities. For the three months ended December 31, 2022, financial (income), net, primarily consisted of $2.7 million in gains resulting from the remeasurement of warrant liabilities. For the year ended December 31, 2022, financial (income), net, primarily consisted of $3.1 million in gains resulting from the remeasurement of warrant liabilities.
 
(2)  For the three months ended December 31, 2022, non-recurring expenses primarily consisted of a $5.5 million accrual for estimated litigation expenses, partially offset by one-time savings related to marketing expenses. For the year ended December 31, 2022, non-recurring expenses primarily consisted of a $5.5 million accrual for estimated litigation expenses.


9